We’re taking a nearly 300% profit on a hot drug stock — adhering to an investing rule to live by

Shortly after the opening bell, we’ll be selling 10 shares of Eli Lilly at roughly $958…

These drugmakers are catching up to Eli Lilly and Novo Nordisk in weight loss treatments

The lucrative market for weight loss drugs won’t stay a duopoly forever. With billions at stake,…

Why half of all workers may struggle to get weight-loss drug health insurance coverage

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City…

Promise of Eli Lilly’s weight-loss drug for sleep apnea adds another reason to own the stock

Eli Lilly ‘s weight-loss drug Zepbound showed promise as a treatment for sleep apnea — giving…

Analysts predicted new obesity medicines would be blockbusters. Now they’re raising their forecasts

As new weight loss medications garnered buzz last year, analysts’ forecasts signaled these drugs would be…

Ozempic, Wegovy may curb drinking, smoking and other addictive behaviors – here’s what we know

An Ozempic (semaglutide) injection pen is seen on a kitchen table in Riga, Latvia on 06…

Novo Nordisk to acquire obesity drug maker Inversago Pharma for up to $1 billion

Liselotte Sabroe | Afp | Getty Images Novo Nordisk on Thursday said it will acquire Inversago…

Eli Lilly says obesity drug helped boost weight loss to 26%, highest seen in late-stage trials

The Eli Lilly logo is shown on one of the company’s offices in San Diego, California,…

EU expands Wegovy, Ozempic probe over suicide risks to include other weight loss, diabetes drugs

In this photo illustration, boxes of the diabetes drug Ozempic rest on a pharmacy counter in…

Few patients continue weight loss drugs like Wegovy after a year — but health costs soar for all

A selection of injector pens for the Wegovy weight loss drug are shown in this photo…

Newseum Global